Search clinical trials for: Delayed Type Hypersensitivity
Total 73789 results
-
NHS Greater Glasgow and ClydeQueen's University, BelfastCompleted
-
The University of Texas Health Science Center at...TerminatedInsulin SensitivityUnited States
-
Herlev and Gentofte HospitalKarolinska InstitutetCompleted
-
University of Texas, El PasoCompletedInsulin Sensitivity/ResistanceUnited States
-
Brugmann University HospitalCompleted
-
NYU Langone HealthSmart PracticeTerminated
-
University of BariCompletedAllergic Contact DermatitisItaly
-
National Institute of Allergy and Infectious Diseases...Completed
-
AB ScienceCompletedIndolent Systemic MastocytosisFrance, United States
-
National Institute of Allergy and Infectious Diseases...TerminatedAsthma | Allergy | Allergic Rhinitis | Atopic Dermatitis | Food Allergy | MastocytosisUnited States
-
Imperial College LondonGlaxoSmithKlineCompleted
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)CompletedKaposi's Sarcoma | HIV-1 InfectionPeru, Kenya, Malawi, Brazil, South Africa, Uganda
-
University Hospital, Gentofte, CopenhagenCompletedType 2 Diabetes | Atopic Dermatitis/EczemaDenmark
-
Peking Union Medical College HospitalUnknownType 2 Diabetes MellitusChina
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesity | Type 2 Diabetes Mellitus | Insulin ResistanceUnited States
-
Tufts Medical CenterAmerican Contact Dermatitis Society (ACDS)CompletedAllergy | Dermatitis | Urticaria | Patch Testing | Contact SensitizationUnited States
-
Sun Yat-sen UniversityCompleted
-
Meir Medical CenterCompletedHypersensitivity, Immediate | Mastocytosis | Insect Bites and StingsIsrael
-
Assaf-Harofeh Medical CenterCompleted
-
Amsterdam UMC, location VUmcCompletedDiabetes Mellitus, Type 2 | Insulin Sensitivity/ResistanceNetherlands
-
University Hospital, ToulouseCompletedIndolent Systemic Mastocytosis | Cutaneous MastocytosisFrance
-
NeXtGen Biologics, Inc.Completed
-
University Hospital, ToulouseCompletedSystemic MastocytosisFrance, Martinique
-
Abramson Cancer Center of the University of PennsylvaniaCompletedAcute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
NeXtGen Biologics, Inc.State University of New York at BuffaloCompletedAllergy | Dermatitis, Allergic Contact | Allergy SkinUnited States
-
University of VirginiaJuvenile Diabetes Research Foundation; DexCom, Inc.CompletedType 1 Diabetes MellitusUnited States
-
University of ChicagoCompletedLymphoma | Breast Neoplasms | Lung Neoplasms | Cancer of Liver | Cancer of KidneyUnited States
-
Allakos Inc.CompletedIndolent Systemic MastocytosisGermany
-
Therapeutic Advances in Childhood Leukemia ConsortiumTerminatedRelapsed Acute Lymphoblastic Leukemia | Allergy to PEG e.Coli Asparaginase | Allergy to Native e.Coli AsparaginaseUnited States
-
GlaxoSmithKlineCompleted
-
Halozyme TherapeuticsCompleted
-
Jason Robert GotlibSeagen Inc.CompletedSystemic Mastocytosis | Mast Cell Leukemia | Aggressive Systemic MastocytosisUnited States
-
Mater Misericordiae University HospitalEuropean Association of Dermatology and VenerologyUnknown
-
National Cheng-Kung University HospitalCompleted
-
AB ScienceCompleted
-
AB ScienceCompleted
-
University of FloridaAmicus TherapeuticsTerminatedPompe Disease | Hypersensitivity Reaction
-
University of BergenCompletedSleep | Circadian Rhythm Sleep Disorder, Delayed Sleep PhaseNorway
-
NHS Greater Glasgow and ClydeUniversity of GlasgowCompletedDiabetes Mellitus, Type 2 | Weight ManagementUnited Kingdom
-
Novartis PharmaceuticalsCompletedLeukemiaUnited States, Belgium, Netherlands, Canada, Austria, Germany, Australia, United Kingdom, Turkey, France, Poland, Norway
-
CSL BehringCompletedHereditary Angioedema Types I and IIUnited States, Spain, Germany, Australia, Canada, Czechia, Hungary, Israel, Italy, Romania, United Kingdom
-
Nordic Society for Pediatric Hematology and OncologyLund University HospitalCompletedAcute Lymphoblastic Leukemia (ALL)Finland, Denmark, Iceland, Norway, Sweden
-
Jason Robert GotlibNovartis; Novartis PharmaceuticalsCompletedSystemic Mastocytosis, Aggressive (ASM) | Leukemia, Mast Cell | Hematological Non-mast Cell Lineage Disease (AHNMD)United States
-
Jason Robert GotlibNational Cancer Institute (NCI)TerminatedSystemic Mastocytosis | Mast Cell Leukemia | Aggressive Systemic MastocytosisUnited States
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | AsthmaUnited States, Slovakia, India, Malaysia, Australia, Former Serbia and Montenegro